The MYCN protein and its involvement in brain tumours
- Researcher: Dr Fredrik Swartling
- Institution: Uppsala University
- Award Amount: £146,965 for 2 years from January 2013
- Cancer Type: Brain Tumour
Dr Swartling and his team have created two different types of genetically modified mice, which allow them to study brain tumours caused by MYCN. They have discovered that one of the reasons that MYCN can accumulate in brain tumours is because it is not being broken down the way it should be. A system known as the ubiquitin system is responsible for breaking down MYCN in healthy brain cells, but in some medulloblastomas this system does not work properly. A molecule called FBW7 works on MYCN and is part of the ubiquitin system, but seems to be mutated in medulloblastoma, or there is much less of the molecule in cancer cells.
With their new grant, they want to study, in detail, the importance of FBW7 and MYCN in the development and growth of brain tumours. They hope to find what causes MYCN-driven brain cancer, and to find new ways to control stabilisation of this protein.
Showing: All projects
The Research That Is Happening Right Now
Explore current projects to see how far-reaching our research is from a global perspective.
See the difference our research projects make.
Our philosophy is very simple: if we believe a project can make a difference in the fight against cancer then we will award a grant to make it happen. We’re not interested in national borders or any kind of geographical bias, just the most promising proposals. And that’s the very reason we ask t...Read more
Life in the Lab
Supporters often ask us what type of projects their donations are funding. What does a typical day in the life of a cancer researcher look like? To answer these questions and give you an insight into the vital work your support helps us to fund, we've put together this short video....Read more